AVEXXIN
Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases at the Norwegian University of Science and Technology. Avexxin's goal is to create a therapeutic company based on the discovery and development of novel therapeutics that address the fundamental mechanisms involved in inflammatory diseases.
AVEXXIN
Industry:
Biotechnology Pharmaceutical
Founded:
2005-01-01
Address:
Trondheim, Sor-Trondelag, Norway
Country:
Norway
Website Url:
http://www.avexxin.com
Total Employee:
11+
Status:
Closed
Contact:
+47 73 59 61 07
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS IIS IIS 7 IP-Only Sweden
Similar Organizations
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
Bayer
Bayer offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology.
Current Employees Featured
Investors List
Sarsia Seed Management
Sarsia Seed Management investment in Venture Round - Avexxin
Leiv Eiriksson Invest
Leiv Eiriksson Invest investment in Venture Round - Avexxin
Official Site Inspections
http://www.avexxin.com
- Host name: redirect1-1.ilait.se
- IP address: 62.109.34.30
- Location: Sölvesborg Sweden
- Latitude: 56.0521
- Longitude: 14.5753
- Timezone: Europe/Stockholm
- Postal: 294 32
